Every 8-K that Lifevantage Corporation (LFVN) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow LFVN and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full LFVN filings page.
LifeVantage Corp (LFVN) reported materially weaker results for the fourth quarter and full fiscal year ended June 30, 2026. Q4 revenue was $42.4 million, down 23.1% year over year, with Americas revenue down 24.8% and Asia/Pacific & Europe down 16.9%. Q4 net income was $1.3 million or $0.10 per diluted share, versus $0.15 a year ago, and adjusted EBITDA fell to $2.7 million from $4.8 million.
For fiscal 2026, revenue was $182.6 million, a 20.1% decline from 2025, driven by lower MindBody GLP-1 System sales, fewer orders, and smaller average order size, partially offset by the LoveBiome acquisition. Net income dropped to $5.1 million ($0.40 per diluted share) from $9.8 million ($0.75), and adjusted EBITDA decreased to $13.7 million from $22.1 million. Gross margin remained high at 77.6%, and the company ended the year with $14.9 million in cash, no debt, and $10.2 million of operating cash flow. Active accounts declined 21.2% to 104,000. LifeVantage repurchased about 336,000 shares for $2.0 million and is not issuing fiscal 2027 guidance following a CEO transition.
LifeVantage Corporation’s Board approved the 2026 New Employee Long-Term Incentive Plan on July 31, 2026. The plan is substantially similar to the 2017 Long-Term Incentive Plan, except that incentive stock options cannot be issued and awards may only be granted to recipients eligible under Nasdaq rules.
The plan was adopted by the Board without stockholder approval pursuant to Nasdaq Listing Rule 5635(c)(4) as an inducement plan. The Board initially reserved 1,500,000 shares of common stock for awards, which may only be granted to qualifying new hires or rehires where the grant is an inducement material to entering into employment.
LifeVantage Corporation reported weaker results for the third fiscal quarter ended March 31, 2026. Revenue was $43.7 million, down 25.2% from $58.4 million a year earlier, driven mainly by lower sales of the MindBody GLP-1 System, partly offset by the LoveBiome acquisition.
Gross margin remained high at 79.0%, but operating income declined to $1.7 million from $4.1 million. Net income fell to $1.4 million or $0.11 per diluted share, versus $3.5 million or $0.26. Adjusted EBITDA decreased to $3.2 million from $6.4 million.
Active accounts dropped to 109,000, down 22.1% year over year, reflecting fewer consultants and customers. The company generated $5.5 million of operating cash flow in the first nine months, held $12.5 million in cash with no debt, and raised its quarterly dividend to $0.05 per share, up 11.1%. Management now expects full-year fiscal 2026 revenue, adjusted EBITDA and adjusted EPS to be near the lower end of its prior guidance range.
LifeVantage Corporation is implementing a planned CEO transition. Steven R. Fife will retire as President, Chief Executive Officer and director effective April 30, 2026, and will serve as an executive advisor through September 11, 2026 under a transition agreement that provides continued benefits and partial equity vesting.
Director Michael Beindorff will become Interim CEO from May 1 to August 4, 2026 under a consulting agreement paying $45,833 per month and will leave key board committees during this period. Effective August 5, 2026, the company will appoint industry veteran Terrence O. Moorehead as President, CEO and director with an annual base salary of $850,000, target cash bonus equal to 100% of salary, and a guaranteed $425,000 bonus for the fiscal year ending June 30, 2027.
Moorehead’s equity package includes time-based RSUs valued at $2.8 million and PSUs valued at $4.7 million, with portions prorated for his initial year and PSUs tied to revenue and Adjusted EBITDA margin targets. If terminated without cause or he resigns for good reason, he is eligible for 18 months of salary continuation, health coverage reimbursement, prorated bonus and continued equity vesting, with enhanced benefits in a qualifying change in control scenario.
LifeVantage Corporation filed a current report describing two key updates. The company issued a press release announcing financial results for the three and six months ended December 31, 2025, which is furnished as Exhibit 99.1. The report also discloses that President and Chief Executive Officer Steven R. Fife has decided to retire and will resign as CEO and from the board, with his resignation expected to be effective in April 2026. The company states that Mr. Fife’s decision to retire is not due to any disagreement regarding operations, financial policies, or practices, and additional details are provided in a second press release furnished as Exhibit 99.2.
LifeVantage Corporation disclosed that two senior executives plan to leave the company in December 2025. On December 3, 2025, Chief Marketing Officer Julie Boyster notified the company of her intention to resign from that role effective December 12, 2025 to pursue other business opportunities.
On the same date, Chief Information and Innovation Officer Todd Thompson informed LifeVantage that he intends to resign from his role effective December 24, 2025, also to pursue other business opportunities. These changes affect the leaders overseeing the company’s marketing and information/innovation functions.
LifeVantage Corporation reported final results from its fiscal 2026 annual meeting held on November 6, 2025. Quorum was achieved with 9,571,454 shares (75.41%) represented out of 12,691,009 outstanding as of the record date.
All seven director nominees were elected. Stockholders approved, on an advisory basis, executive compensation with 7,420,820 votes for. They ratified Deloitte & Touche LLP as independent auditor with 9,539,267 votes for. An amendment to the 2017 Long‑Term Incentive Plan was approved with 5,382,441 votes for.
LifeVantage Corporation filed a current report to note that it issued a press release on November 4, 2025 announcing its financial results for the three months ended September 30, 2025. The press release is provided as Exhibit 99.1 and is incorporated by reference for full details of the quarterly performance.
LifeVantage Corporation disclosed that on September 4, 2025 it issued a press release announcing its financial results for the fourth quarter and full fiscal year ended June 30, 2025. The press release is included as Exhibit 99.1 to the current report. The filing notes the furnished information is not being deemed "filed" under the Exchange Act and therefore is not subject to the liabilities of Section 18.